In melanoma, T cell phenotypic characterization of TILs and peripheral blood lymphocytes in patients treated with T-VEC demonstrated increased intratumoral CD8 + T cells, neutrophils, monocytes, and chemokines, as well as increased peripheral CD4 + T cells, CD8 + T cells, and myeloid populations29,30. This evidence concerns the gene CD8A and melanoma.